title: Association of pro/anti-inflammatory cytokine gene variants in renal transplant patients with allograft outcome and cyclosporine immunosuppressant levels.
abstract: T-helper (Th) type 1/Th2 cytokines are key mediators in induction/effecter phases of all immune and inflammatory responses playing role in acute/chronic renal allograft rejection. Association studies lead to identification of patient risk profiles enabling individualization of level of immunosuppressions. We investigated the association of allograft rejection with interleukin-2 (IL-2), IL-4, IL-6, tumor necrosis factor-alpha (TNF-alpha) -308, transforming growth factor-beta (TGF-beta) (C-del, codon 10 and 25) gene variants in 184 renal transplant recipients and 180 controls. These cytokine genotypes were also evaluated with cyclosporine levels (C2) at one month in 135 stable recipients. High producing genotypes B1B1 of IL-4 and AA of TNF-alpha alpha308 showed significant association with rejection of allograft. The dose-adjusted C2 levels were significantly lower in patients with the high producing genotype T/T of IL-2 and heterozygous G/C of TGF-beta codon 25 (P = 0.012 and 0.010, respectively). Haplotype frequencies were comparable in subjects for TGF-beta codon-10 and 25. Combined inter-gene interaction showed high risk for rejection in recipients with high producing genotype B1B1 of IL-4 and AA of TNF-alpha and high TNF-alpha (AA) with low TGF-beta (CC or Pro/Pro). In conclusion, association of IL-4 VNTR and TNF-alpha -308 suggested the involvement of these cytokines contributing to pathogenesis of allograft rejection. Recipients with TT genotype of IL-2 and GC of TGF-beta codon 25 having low C2 levels may require higher cyclosporine dosage. Combined analysis of gene-gene interaction demonstrated synergistic effect of cytokines increasing risk for rejection. Thus, this information may help in pre-assessment of allograft outcome and to optimize cyclosporine therapy in post-transplant patients.
authors.affiliation: Department of Urology and Renal Transplantation, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Raebareli Road, Lucknow 226014, Uttar Pradesh, India.
authors.forename: Parmeet Kaur
authors.initials: PK
authors.lastname: Manchanda
authors.forename: Anant
authors.initials: A
authors.lastname: Kumar
authors.forename: Raj K
authors.initials: RK
authors.lastname: Sharma
authors.forename: Himanshu
authors.initials: H
authors.lastname: Goel
authors.forename: Rama Devi
authors.initials: RD
authors.lastname: Mittal
references.citation: Transplant Proc. 2001 Feb-Mar;33(1-2):348-9
references.pmid: 11266855
references.citation: J Nephrol. 2004 Nov-Dec;17(6):794-9
references.pmid: 15593053
references.citation: J Am Soc Nephrol. 1991 Aug;2(2 Suppl 1):S45-52
references.pmid: 1932643
references.citation: J Am Soc Nephrol. 2005 May;16(5):1371-83
references.pmid: 15788474
references.citation: Tissue Antigens. 2004 Dec;64(6):660-6
references.pmid: 15546338
references.citation: Clin Exp Immunol. 2004 Oct;138(1):145-50
references.pmid: 15373917
references.citation: J Am Soc Nephrol. 1998 Dec;9(12):2302-7
references.pmid: 9848784
references.citation: DNA Cell Biol. 2007 Mar;26(3):172-7
references.pmid: 17417945
references.citation: Transplantation. 2007 Feb 27;83(4):448-57
references.pmid: 17318078
references.citation: Clin Chem. 2004 Jan;50(1):141-51
references.pmid: 14709642
references.citation: Transpl Immunol. 2003 Jan-Mar;11(1):107-19
references.pmid: 12727482
references.citation: Transplantation. 2005 Dec 27;80(12):1773-82
references.pmid: 16378074
references.citation: J Urol. 2005 Aug;174(2):753-6
references.pmid: 16006970
references.citation: Clin Exp Pharmacol Physiol. 2006 May-Jun;33(5-6):525-32
references.pmid: 16700889
references.citation: Kidney Int. 1999 Jul;56(1):281-8
references.pmid: 10411704
references.citation: Transpl Immunol. 2001 Feb;8(4):259-65
references.pmid: 11316069
references.citation: Transplantation. 2004 Nov 27;78(10):1422-8
references.pmid: 15599305
references.citation: Transplant Proc. 2005 Mar;37(2):764-6
references.pmid: 15848524
references.citation: Transplant Proc. 2005 May;37(4):1760-1
references.pmid: 15919456
references.citation: Transpl Int. 2003 Aug;16(8):464-73
references.pmid: 12712237
references.citation: Mol Diagn Ther. 2006;10(4):205-19
references.pmid: 16884324
references.citation: Urol Res. 2001 Dec;29(6):412-6
references.pmid: 11828995
references.citation: Transplant Proc. 2005 Jun;37(5):2041-3
references.pmid: 15964333
references.citation: Nucleic Acids Res. 1988 Feb 11;16(3):1215
references.pmid: 3344216
references.citation: Transplant Proc. 2007 May;39(4):954-7
references.pmid: 17524861
references.citation: Transplant Proc. 2003 Jun;35(4):1344-5
references.pmid: 12826155
references.citation: Int J Immunogenet. 2007 Apr;34(2):87-90
references.pmid: 17373932
references.citation: Exp Clin Transplant. 2006 Jun;4(1):445-50
references.pmid: 16827641
references.citation: Kidney Int. 1999 Feb;55(2):713-23
references.pmid: 9987096
references.citation: Clin Chim Acta. 2006 Aug;370(1-2):152-7
references.pmid: 16545788
references.citation: Transplantation. 2004 Feb 27;77(4):548-52
references.pmid: 15084933
references.citation: Immunogenetics. 2007 Feb;59(2):159-65
references.pmid: 17203290
references.citation: Transpl Immunol. 2006 Nov;16(3-4):194-9
references.pmid: 17138053
references.citation: Transplantation. 2000 Nov 27;70(10):1485-91
references.pmid: 11118095
references.citation: Transplantation. 2001 Aug 27;72(4):720-6
references.pmid: 11544437
references.citation: Kidney Int. 2004 Jan;65(1):106-15
references.pmid: 14675041
references.citation: Transplant Proc. 1999 Feb-Mar;31(1-2):734-6
references.pmid: 10083313
references.citation: Transpl Immunol. 1999 Jun;7(2):127-8
references.pmid: 10544444
references.citation: Transpl Immunol. 2005 Mar;14(1):49-52
references.pmid: 15814282